Free Trial

Dynamic Advisor Solutions LLC Lowers Holdings in HCA Healthcare, Inc. (NYSE:HCA)

HCA Healthcare logo with Medical background

Dynamic Advisor Solutions LLC trimmed its holdings in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 50.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 2,777 shares of the company's stock after selling 2,860 shares during the quarter. Dynamic Advisor Solutions LLC's holdings in HCA Healthcare were worth $834,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also modified their holdings of HCA. Terra Nova Asset Management LLC increased its stake in HCA Healthcare by 0.3% during the 3rd quarter. Terra Nova Asset Management LLC now owns 8,112 shares of the company's stock worth $3,297,000 after buying an additional 26 shares during the period. Massmutual Trust Co. FSB ADV increased its position in shares of HCA Healthcare by 7.4% during the third quarter. Massmutual Trust Co. FSB ADV now owns 421 shares of the company's stock worth $171,000 after acquiring an additional 29 shares during the period. Waldron Private Wealth LLC grew its stake in HCA Healthcare by 1.8% during the 3rd quarter. Waldron Private Wealth LLC now owns 1,681 shares of the company's stock worth $683,000 after purchasing an additional 29 shares in the last quarter. Brookstone Capital Management boosted its stake in shares of HCA Healthcare by 0.7% in the 3rd quarter. Brookstone Capital Management now owns 4,065 shares of the company's stock valued at $1,652,000 after buying an additional 30 shares during the period. Finally, UMB Bank n.a. increased its stake in shares of HCA Healthcare by 2.4% during the third quarter. UMB Bank n.a. now owns 1,301 shares of the company's stock worth $529,000 after buying an additional 30 shares during the period. Institutional investors and hedge funds own 62.73% of the company's stock.

HCA Healthcare Stock Performance

Shares of HCA Healthcare stock traded up $19.11 during trading hours on Monday, hitting $332.18. 2,805,821 shares of the company were exchanged, compared to its average volume of 1,778,044. The business has a 50-day moving average of $313.49 and a 200-day moving average of $353.13. HCA Healthcare, Inc. has a 1 year low of $281.61 and a 1 year high of $417.14. The company has a current ratio of 1.12, a quick ratio of 1.00 and a debt-to-equity ratio of 48.71. The stock has a market capitalization of $84.14 billion, a price-to-earnings ratio of 14.92, a P/E/G ratio of 1.09 and a beta of 1.64.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its quarterly earnings results on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.52% and a return on equity of 520.98%. During the same quarter in the previous year, the company earned $5.90 earnings per share. As a group, analysts expect that HCA Healthcare, Inc. will post 21.75 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, March 31st. Shareholders of record on Monday, March 17th will be given a dividend of $0.72 per share. This is a positive change from HCA Healthcare's previous quarterly dividend of $0.66. This represents a $2.88 annualized dividend and a dividend yield of 0.87%. The ex-dividend date of this dividend is Monday, March 17th. HCA Healthcare's payout ratio is presently 11.85%.

Analyst Ratings Changes

HCA has been the topic of a number of recent analyst reports. StockNews.com downgraded shares of HCA Healthcare from a "strong-buy" rating to a "buy" rating in a research report on Monday, November 4th. TD Cowen decreased their price target on HCA Healthcare from $450.00 to $440.00 and set a "buy" rating for the company in a report on Monday, October 28th. Oppenheimer boosted their target price on HCA Healthcare from $390.00 to $400.00 and gave the stock an "outperform" rating in a research note on Monday, October 28th. Bank of America reduced their price objective on shares of HCA Healthcare from $380.00 to $370.00 and set a "buy" rating for the company in a research report on Monday. Finally, Cantor Fitzgerald reiterated an "overweight" rating and set a $405.00 price target on shares of HCA Healthcare in a research note on Monday. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $382.19.

View Our Latest Analysis on HCA

Insider Activity at HCA Healthcare

In other news, insider Erol R. Akdamar sold 2,900 shares of the firm's stock in a transaction on Thursday, November 14th. The stock was sold at an average price of $353.00, for a total value of $1,023,700.00. Following the completion of the transaction, the insider now owns 6,843 shares in the company, valued at $2,415,579. This trade represents a 29.76 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, SVP Phillip G. Billington sold 3,897 shares of the stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the completion of the sale, the senior vice president now directly owns 52,702 shares in the company, valued at approximately $18,445,700. The trade was a 6.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.60% of the company's stock.

About HCA Healthcare

(Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Further Reading

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Should You Invest $1,000 in HCA Healthcare Right Now?

Before you consider HCA Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.

While HCA Healthcare currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Nuclear Energy’s Comeback: 7 Stocks to Watch in 2025

Nuclear Energy’s Comeback: 7 Stocks to Watch in 2025

Nuclear energy is making a resurgence! Watch to find out which seven nuclear energy stocks could deliver long-term gains in the transition to cleaner energy.

Related Videos

Pelosi Bets Big on AI: Her Top 5 Stock Picks
Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines